Naproxen and Cromolyn as New Glycogen Synthase Kinase 3β Inhibitors for Amelioration of Diabetes and Obesity: An Investigation by Docking Simulation and Subsequent In Vitro/In Vivo Biochemical Evaluation

Publisher: John Wiley & Sons Inc

E-ISSN: 1099-0461|27|9|425-436

ISSN: 1095-6670

Source: JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (FORMERLY JOURNAL OF BIOCHEMICAL TOXICOLOGY), Vol.27, Iss.9, 2013-09, pp. : 425-436

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract